45 results about "PAEONIA Extract" patented technology

The invention discloses a composition and preparation method for multi-target inhibition of melanin and its application in cosmetics. In total, the chuanxiong extract is 30-60%, the peony extract is 20-40%, and the rattan tea extract is 10-40%. Inhibition of melanin by the prescription of the present invention is embodied in the form of multiple targets, and the prescription can ensure safety while ensuring the effect of suppressing melanin content.

A combined plant medicine for treating type II diabetes and insulin sensitivity, its extract and its extraction method. It is made from the following raw materials: Cortex Moutan, Alisma, Radix Polygoni Multiflori, Polygonatum, Anemarrhena, Coptidis. Coptis chinensis is extracted with ethanol under reflux, ethanol is recovered, and concentrated to obtain Coptis chinensis ointment; Moutan cortex is infiltrated with sodium chloride solution, steam distilled, left standing, and the crystals are collected and dried to obtain paeonol from Moutan cortex extract; Moutan cortex dregs and Zhimu , Alisma, Polygonum Polygoni Multiflori, and Polygonatum Polygonatum were extracted with ethanol under reflux, recovered ethanol, concentrated, combined with Coptis chinensis paste, mixed, dried, crushed into fine powder, added paeonol, and obtained the extract. The invention has the functions of nourishing kidney and liver, clearing heat and resolving phlegm, can treat type 2 diabetes and improve insulin resistance, is safe and effective, has little side effects, and has definite curative effect on treating type 2 diabetes and improving insulin resistance.

The invention provides a traditional Chinese medicine granular preparation containing red paeonia extractive and a preparation method thereof. In the invention, traditional Chinese medicine spheroidized particles are prepared by traditional Chinese medicine extractive and carriers acceptable in pharmacy. The outline of the traditional Chinese medicine spheroidized particles takes sphere shape or round type shape. The density of the preparation is 0.6-1.3 g / ml. The spheroidized particles of the invention has low single dose, is convenient in use, can be served as intermediate products of capsules, and also can be used for developing a traditional Chinese medicine controlled release preparation.

The invention provides a tree peony root bark, as well as a preparation method and application thereof. The preparation method comprises the following steps: extracting a tree peony root bark medicinal material with organic alcohol aqueous solution, concentrating and drying to obtain the tree peony root bark extract. The tree peony root bark extract can inhibit glucose-regulated protein GRP78, and is used for resisting virus. In-vitro experiments prove that: the tree peony root bark extract has remarkable effect in resisting hepatitis B virus secretion, has small toxicity to normal cells and liver cancer cells, and has excellent application prospect.

The invention discloses a natural anti-wrinkle and anti-aging skin care composition and its application in cosmetics. The skin care composition is composed of the following components by weight percentage: 1-12% of oat kernel oil, 1-15% of ylang-ylang oil, 1-10% of Ophiopogon japonicus extract, 1-13% of ginkgo leaf extract, 1~12% peony extract, 1~11% peony extract, 1~12% ginger root extract, 1~15% chayote extract, 1~10% centella asiatica extract, 1~13% salvia root extract , turmeric root essential oil 1-13%, red wine extract 1-10%; the skin care composition is added in an amount of 2-10wt% in the cosmetics. The invention can effectively remove free radicals, reduce skin fine lines and delay skin aging, and can be used as an additive in various cosmetics, has good stability, does not contain any synthetic chemical substances, and has safe and non-irritating ingredients.

The present invention relates to a composition containing the active components of paeoniflorin and albiflorin extracted and seperated from Paeonia lactifora Pall, the total content of the two components being between 50% and 95 % and weight ratio of the paeoniflorin and albiflorin in the composition being 1:10-10:1. The composition is applicable for preparing various simple prescription medicine preparations, delayed releasing preparation or controlled releasing preparation, preparation by body cavity administration, spray administration, transdermal absorption or oral administration; injection preparation or transfused fluid preparation; or for combining with other medicine (containing Chinese traditional medicine extract or effective component) to form compound medicine preparation by replacing peony extract or peony total glycosides. The composition is suitable for preparing medicine for treating leucopenia, throbocytopenia and achreocythemia of different causes.